From: Survival after the diagnosis of breast or colorectal cancer in the GAZA Strip from 2005 to 2014
Cases | Deaths (N = 93) | ||
---|---|---|---|
N | N (%) | HR (95% CI)a | |
Age at diagnosis (years) | |||
< 55 | 98 | 47 (48.0) | 1b |
≥ 55 | 80 | 46 (57.5) | 1.39 (0.93–2.09) |
Stage c | |||
Localized | 33 | 10 (30.3) | 1b |
Regional/Distant | 107 | 57 (53.3) | 1.93 (0.98–3.80) |
Missing | 38 | 26 (68.4) | 2.32 (1.10–4.91) |
Grade | |||
Well and Moderately differentiated | 75 | 31 (41.3) | 1b |
Poorly differentiated and Undifferentiated | 70 | 42 (60.0) | 1.67 (1.04–2.69) |
Missing | 33 | 20 (60.6) | 1.33 (0.72–2.44) |
Surgery c | |||
No | 18 | 14 (77.8) | 1b |
Yes | 156 | 76 (48.7) | 0.29 (0.16–0.53) |
Chemotherapy c | |||
No | 38 | 23 (60.5) | 1b |
Yes | 136 | 67 (49.3) | 0.58 (0.36–0.94) |
Radiotherapy c | |||
No | 81 | 46 (56.8) | 1b |
Yes | 93 | 44 (47.3) | 0.89 (0·57–1·39) |
Hormone therapy c | |||
No | 109 | 63 (57.8) | 1b |
Yes | 65 | 27 (41.5) | 0.53 (0.33–0.84) |
Number of therapies c | |||
0–1 | 25 | 20 (80.0) | 1b |
2 | 55 | 29 (52.7) | 0.32 (0.18–0.58) |
3 | 56 | 23 (41.1) | 0.25 (0.13–0.48) |
4 | 38 | 18 (47.4) | 0.26 (0.13–0.51) |